|
| 37870438 | Impact of Rare and Multiple Concurrent Gene Fusions on Diagnostic DNA Methylation Classifier in Brain Tumors. | Mol Cancer Res | 2024 |
| 37163349 | PTCy, abatacept, and a short course of tacrolimus for GVHD prevention after haploidentical transplantation. | Blood Adv | 2023 |
| 36240479 | Genomic Microsatellite Signatures Identify Germline Mismatch Repair Deficiency and Risk of Cancer Onset. | J Clin Oncol | 2023 |
| 36335802 | The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science. | Neoplasia | 2023 |
| 37584601 | Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways. | Cancer Discov | 2023 |
| 37476329 | Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors-A prospective study and guidelines for clinical testing. | Neurooncol Adv | 2023 |
| 36950217 | Phase II study of everolimus for recurrent or progressive pediatric ependymoma. | Neurooncol Adv | 2023 |
| 35137228 | Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma. | Neuro Oncol | 2022 |
| 35997552 | Clinical, Pathological, and Molecular Characteristics of Diffuse Spinal Cord Gliomas. | J Neuropathol Exp Neurol | 2022 |
| 36382108 | Phase I dose escalation and expansion trial of single agent ONC201 in pediatric diffuse midline gliomas following radiotherapy. | Neurooncol Adv | 2022 |
| 34594573 | Long-term neuropsychological outcomes of survivors of young childhood brain tumors treated on the Head Start II protocol. | Neurooncol Pract | 2021 |
| 33945292 | Survival Benefit for Individuals With Constitutional Mismatch Repair Deficiency Undergoing Surveillance. | J Clin Oncol | 2021 |
| 31375903 | Subgroup-specific outcomes of children with malignant childhood brain tumors treated with an irradiation-sparing protocol. | Child's Nervous System | 2020 |
| 32187454 | Pineoblastoma in children less than six years of age: The Head Start I, II, and III experience. | Pediatr Blood Cancer | 2020 |
| 32304218 | Excellent outcome of young children with nodular desmoplastic medulloblastoma treated on "Head Start" III: a multi-institutional, prospective clinical trial. | Neuro Oncol | 2020 |
| 32766689 | The Role of Liquid Biopsies in Pediatric Brain Tumors. | Journal of Neuropathology and Experimental Neurology | 2020 |
| 32594172 | Exploring DNA Methylation for Prognosis and Analyzing the Tumor Microenvironment in Pleomorphic Xanthoastrocytoma. | J Neuropathol Exp Neurol | 2020 |
| 32682450 | Orbital Rosai-Dorfman disease initially diagnosed as IgG4-related disease: a case report. | Acta neuropathologica communications | 2020 |
| 31456142 | Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201. | J Neurooncol | 2019 |
| 29741745 | Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine glioma. | Neuro Oncol | 2018 |
| 28905508 | Tandem thiotepa with autologous hematopoietic cell rescue in patients with recurrent, refractory, or poor prognosis solid tumor malignancies. | Pediatr Blood Cancer | 2018 |
| 30030436 | Recurrent homozygous deletion of DROSHA and microduplication of PDE4DIP in pineoblastoma. | Nat Commun | 2018 |
| 29982174 | Fair, just and compassionate: A pilot for making allocation decisions for patients requesting experimental drugs outside of clinical trials. | J Med Ethics | 2018 |
| 30392092 | Pre-irradiation intensive induction and marrow-ablative consolidation chemotherapy in young children with newly diagnosed high-grade brainstem gliomas: report of the "head-start" I and II clinical trials. | J Neurooncol | 2018 |
| 23652864 | Noncarboplatin-induced Sensorineural Hearing Loss in a Patient With an Intracranial Nongerminomatous Germ Cell Tumor. | Journal of Pediatric Hematology/Oncology | 2016 |
| 27332770 | Outcome of young children with high-grade glioma treated with irradiation-avoiding intensive chemotherapy regimens: Final report of the Head Start II and III trials. | Pediatr Blood Cancer | 2016 |
| 26726947 | Phase I study of temozolomide in combination with thiotepa and carboplatin with autologous hematopoietic cell rescue in patients with malignant brain tumors with minimal residual disease. | Bone Marrow Transplant | 2016 |
| 27406584 | Utility of MRI versus tumor markers for post-treatment surveillance of marker-positive CNS germ cell tumors. | Journal of Neuro-Oncology | 2016 |
| 26950375 | Decreased morbidity and mortality of autologous hematopoietic transplants for children with malignant central nervous system tumors: the 'Head Start' trials, 1991-2009. | Bone Marrow Transplant | 2016 |
| 27203542 | High Incidence of Veno-Occlusive Disease With Myeloablative Chemotherapy Following Craniospinal Irradiation in Children With Newly Diagnosed High-Risk CNS Embryonal Tumors: A Report From the Children's Oncology Group (CCG-99702). | Pediatr Blood Cancer | 2016 |
| 26054044 | Relapse and outcome patterns of patients with central nervous system mixed malignant germ cell tumors treated without irradiation: Findings from the third international central nervous system (CNS) germ cell tumor (GCT) study. | Pediatr Blood Cancer | 2015 |
| 25787675 | Persistent racial and ethnic differences in location of death for children with cancer. | Pediatric Blood and Cancer | 2015 |
| 25662896 | Choroid plexus carcinoma in children: the Head Start experience. | Pediatr Blood Cancer | 2015 |
| 25308760 | Ifosfamide and vinorelbine is an effective reinduction regimen in children with refractory/relapsed Hodgkin lymphoma, AHOD00P1: a children's oncology group report. | Pediatric Blood and Cancer | 2015 |
| 25961775 | Risk factors and timing of relapse after allogeneic transplantation in pediatric ALL: for whom and when should interventions be tested? | Bone Marrow Transplant | 2015 |
| 24789527 | Late effects in survivors of childhood CNS tumors treated on Head Start I and II protocols. | Pediatr Blood Cancer | 2014 |
| 23934933 | Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly-diagnosed with central nervous system atypical teratoid/rhabdoid tumors: the Head Start III experience. | Pediatr Blood Cancer | 2014 |
| 23929729 | Pilot study assessing a seven-day continuous intrathecal topotecan infusion for recurrent or progressive leptomeningeal metastatic cancer. | J Oncol Pharm Pract | 2014 |
| 24497539 | The addition of sirolimus to tacrolimus/methotrexate GVHD prophylaxis in children with ALL: a phase 3 Children's Oncology Group/Pediatric Blood and Marrow Transplant Consortium trial. | Blood | 2014 |
| 24477622 | Prognostic significance of telomere maintenance mechanisms in pediatric high-grade gliomas. | J Neurooncol | 2014 |
| 24615997 | A retrospective analysis of recurrent intracranial ependymoma. | Pediatr Blood Cancer | 2014 |
| 23508296 | Outcome of infants and young children with newly diagnosed ependymoma treated on the "Head Start" III prospective clinical trial. | J Neurooncol | 2013 |
| 24140199 | Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis. | Lancet Oncol | 2013 |
| 20526792 | Quality of life and behavioral follow-up study of Head Start I pediatric brain tumor survivors. | J Neurooncol | 2011 |
| 20623246 | Prospective neuraxis MRI surveillance reveals a high risk of leptomeningeal dissemination in diffuse intrinsic pontine glioma. | Journal of Neuro-Oncology | 2011 |
| 20052775 | Neuropsychological functioning of children treated with intensive chemotherapy followed by myeloablative consolidation chemotherapy and autologous hematopoietic cell rescue for newly diagnosed CNS tumors: an analysis of the Head Start II survivors. | Pediatr Blood Cancer | 2010 |
| 20486171 | Intensive multimodality therapy for patients with stage 4a metastatic retinoblastoma. | Pediatric Blood and Cancer | 2010 |
| 19896544 | Immunotherapy for pediatric central nervous system tumors. | Biology of Blood and Marrow Transplantation | 2010 |
| 20387263 | A primary cardiac sarcoma with features of a desmoplastic small round cell tumor in an adolescent male. | Journal of Pediatric Hematology/Oncology | 2010 |
| 20167818 | High-dose carboplatin, thiotepa, and etoposide with autologous stem cell rescue for patients with previously irradiated recurrent medulloblastoma. | Neuro Oncol | 2010 |